GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 20701 - 20750 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
6MJQ A0A5B9 Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex
6MJQ A0N8J3 Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex
6MJQ A2NTY6 Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex
6MK0 P06756 Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161
6MK0 P05106 Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161
6MKB P41274 Crystal structure of murine 4-1BB ligand
6MKZ P41274 Crystal structure of murine 4-1BB/4-1BBL complex
6MKZ P20334 Crystal structure of murine 4-1BB/4-1BBL complex
6ML8 Q2IBI1 Crystal structure of hemagglutinin from H1N1 Influenza A virus A/Denver/57 bound to the C05 antibody
6ML8 6ML8 Crystal structure of hemagglutinin from H1N1 Influenza A virus A/Denver/57 bound to the C05 antibody
6MLF Q8PGN7 Crystal structure of X. citri phosphoglucomutase in complex with 6-fluoro glucose 1-phosphate
6MLH Q8PGN7 Crystal structure of X. citri phosphoglucomutase in complex with GLUCOPYRANOSYL-1-METHYL-PHOSPHONIC ACID
6MLM B2LVD7 H7 HA0 in complex with Fv from H7.5 IgG Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, Heavy chain Fv of H7.5 Fab, Light chain Fv of H7.5 Fab
6MLM 6MLM H7 HA0 in complex with Fv from H7.5 IgG Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, Heavy chain Fv of H7.5 Fab, Light chain Fv of H7.5 Fab
6MLW Q8PGN7 Crystal structure of X. citri phosphoglucomutase in complex with 2-fluoro mannosyl-1-methyl-phosphonic acid
6MM9 P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MM9 Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMB P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMB Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMI P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Splayed-Open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMI Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Splayed-Open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMJ P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMJ Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMS P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMS Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMT P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMT Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMU P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMU Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMW P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024